Vanflyta
Country: European Union
Language: Czech
Source: EMA (European Medicines Agency)
Public Assessment Report
(PAR)
06-01-2020
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
quizartinib dihydrochlorid
Available from:
Daiichi Sankyo Europe GmbH
ATC code:
L01XE
INN (International Name):
quizartinib
Therapeutic group:
Antineoplastická činidla
Therapeutic area:
Leukemie, myeloidní, akutní
Therapeutic indications:
Léčba akutní myeloidní leukémie.
Authorization status:
Odmítl
